Update on Antifungal Therapy

This publication has 11 references indexed in Scilit:

• Comparison of the modified Stokes' method of susceptibility testing with results obtained using MIC methods and British Society of Antimicrobial Chemotherapy breakpoints
  Journal of Antimicrobial Chemotherapy, 1998
• In Vitro Activity of Two Echinocandin Derivatives, LY303366 and MK-0991 (L-743,792), Against Clinical Isolates of Aspergillus, Fusarium, Rhizopus, and Other Filamentous Fungi
  Diagnostic Microbiology and Infectious Disease, 1998
• In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)
  Antimicrobial Agents and Chemotherapy, 1997
• Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis
  Antimicrobial Agents and Chemotherapy, 1997
• A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei
  Antimicrobial Agents and Chemotherapy, 1997
• Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans
  Antimicrobial Agents and Chemotherapy, 1997
• Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia
  British Journal of Haematology, 1997
• In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens
  Antimicrobial Agents and Chemotherapy, 1997
• Toxicity and therapeutic effects in mice of liposome-encapsulated nystatin for systemic fungal infections
  Antimicrobial Agents and Chemotherapy, 1987
• Formulation, toxicity, and antifungal activity in vitro of liposome-encapsulated nystatin as therapeutic agent for systemic candidiasis
  Antimicrobial Agents and Chemotherapy, 1987